Tokyo-based Fast Track Initiative has led a $7.2-million funding round into Modulus Discovery while drug-maker Takeda and Third Rock Ventures have invested $60 million in the Series A funding of Ambys Medicine.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in